Nobles Medical Technologies II's Launches Sales in Europe for its Minimally Invasive NobleStitch® EL System for PFO Closure

Share Article

Nobles Medical Technologies II today announced that it has officially launched sales in Europe for its NobleStitch EL PFO Closure System. Nobles Medical Technologies II has started its initial sales launch in Germany and the UK and will be expanding throughout Europe, Russia and the CIS countries over the next 2 quarters.

Nobles Medical Technologies II's NobleStitch EL system received CE Mark in 2009, followed by its new indication for use “Cardiovascular Suturing and PFO Closure “ in 2012, which was announced at the CSI meeting in Frankfurt last June and is now commercially available in Germany and the UK. The device is delivered to the heart through the femoral vein, a blood vessel in the leg, and is designed to suture closed the PFO (Patent Foramen Ovale). This is the first technology that emulates the surgical procedure using suture rather than implanting a large metal “umbrella” device. Prof. Dr. Anthony Nobles, CEO of NMT2 said “We are very proud to bring this technology to patients who suffer from the debilitating effects of recurrent stroke and severe migraine. These patients will now have the first alternative to a large metal implant in their heart or the long term issues associated with on-pump open heart surgery”.

About Patent Foramen Ovale (PFO)
A PFO is a tunnel that exists between the left and right atrium of the heart. The tunnel, which is part of the normal fetal anatomy, should close shortly after birth. In 27% of the population the tunnel never closes. This tunnel can then allow clots and other chemicals to pass from the right to the left side of the heart freely bypassing the filter of the lungs. These clots and chemicals can cause strokes and other conditions such as severe migraines.

About the NobleStitch EL System
Nobles Medical Technologies II's NobleStitch EL is a catheter based system that allows a physician to place a suture in the PFO tunnel in the heart through a percutaneous puncture in the leg, in many cases under a local anesthetic in a catheter lab rather than an operating room. This eliminates the need for open heart surgery or placement of a large metallic implant in the heart. The NobleStitch is not a “device” or mechanical implant it only places a simple polyproylyne suture in the heart. By closing the hole or PFO, the therapy will reduce or eliminate the shunting from the right to the left side of the heart allowing the lungs to filter the clots and other chemicals from making it to the brain, potentially halting strokes and severe migraines and enabling patients to live a higher-quality life.

About Nobles Medical Technologies II
Nobles Medical Technologies II is a global structural heart company devoted to improving life through the development of its products and technologies. Nobles Medical Technologies II is focused on suture based solutions for the septum.
Visit Nobles Medical Technologies II at:

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ben Brosch
Nobles Medical Technologies
+1 714-427-0398
Email >
Visit website